Medtech
Alpha Tau Medical Ltd, developer of the innovative alpha-radiation cancer therapy Alpha DaRT, and Tolmar International Ltd., one of the strongest commercial players in the U.S. urology, oncology, endocrinology and paediatric endocrinology markets, have announced a strategic collaboration agreement to develop and commercialise Alpha DaRT for the treatment of prostate cancer in the United States. [...]
Emergency medical service SAMU de Paris has achieved an out-of-hospital cardiac arrest survival rate four times the global average, through a rescue therapy called ECPR. Previously largely confined to hospitals, deployment on Paris streets has been supported in part with the help of handheld ultrasound technology and AR glasses from international health tech company Mindray. [...]
Neurovalens has received FDA approval for its PTSD device, paving the way for the Northern Irish company to expand sales in the US. The Belfast group has secured De Novo approval from the US Food and Drug Administration for its technology designed to treat post-traumatic stress disorder. The system works by using low-level [...]
ReVision Implant has secured €4m in funding for its brain implant for severe blindness, as it moves from preclinical development towards first-in-human studies. The Belgian neurotechnology company said the oversubscribed funding round from private investors marks a key step in its transition from preclinical development to clinical exploration. The round included both existing investors and [...]
Phoenix Hospital Group has launched a new suite of Executive Health Assessments using Deep Resolve MRI technology, offering faster scan times and higher-resolution imaging for busy professionals seeking quicker access to preventative healthcare. The new service, launching at Phoenix Hospital Group in London’s prestigious Harley Street Health District, is part of ‘Phoenix Preventative Health’ which reflects growing demand for [...]
Boston Scientific Corporation has announced positive results from the pivotal FRACTURE Investigational Device Exemption (IDE) trial evaluating the use of the SEISMIQ 4CE Coronary Intravascular Lithotripsy Catheter to treat patients with severely calcified coronary artery disease (CAD). The study met its primary safety and effectiveness endpoints, demonstrating high rates of freedom from major adverse cardiac [...]
UroMems has raised US$60m from Ajax Health Fund I to support pivotal trials of its UroActive implant in the US and France ahead of regulatory submissions. The round is the company’s largest fundraising to date and comes less than a year after its US$47m Series C financing in June 2024. Co-founder Hamid Lamraoui [...]
Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced the successful completion of its Series C funding round, raising US$21 million. The strong institutional demand validates the company’s therapeutic approach and competitive positioning. The round includes participation from new and existing investors, including the European Innovation Council (EIC), Junson [...]
Tens of thousands of cancer patients are set to benefit from a new immunotherapy jab on the NHS, which can be given in 60 seconds. The NHS is rolling out a new injectable form of pembrolizumab, sold as Keytruda, which can reduce treatment time by up to 90 per cent, to help patients spend less [...]
The UK medical technology sector has an annual turnover of over £26.4 billion. The opportunities for growth are huge, driven by developments in diagnostics, remote monitoring and patient care and enabled by AI, the Internet of Medical Things (IoMT), and software-enabled products. There are many challenges for MedTech companies in this fast growing market, from [...]
